Michael Weiss

Michael A. Weiss (1975, OH), MD, PhD is a Distinguished Professor at Indiana University and Robert A. Harris Chair of Biochemistry at the IU School of Medicine. A Presidential Scholar in 1975 (Ohio) and former member of the White House Commission on Presidential Scholars (under Pres. Jimmy Carter), Dr. Weiss has long investigated the structure and function of insulin, a body of work recognized in 2020 by the JDRF’s Gerold and Kayla Grodsky Basic Research Scientist Award. His laboratory also works in reproductive endocrinology to study children with differences in sexual development (DSD). Dr. Weiss is a graduate of Harvard College, the Harvard-MIT Program in Health Sciences & Technology (HST) and MD-PhD Program at Harvard Medical School. With clinical training at the Brigham & Women’s Hospital, he is Board Certified in Internal Medicine. Holding >20 patents in insulin technologies, Dr. Weiss is a founder and Chief Innovation Officer of Thermalin, Inc. Following Ph.D. research under Prof. Martin Karplus (Harvard Chemistry) and clinical training, Dr. Weiss joined the Endocrine Unit at the Massachusetts General Hospital (1988-1994). He was a member of the junior faculty of the Department of Biological Chemistry & Molecular Pharmacology at Harvard Medical School (1988-1994), Professor at the University of Chicago (1994-1999), and Cowan-Blum Professor and Department Chair at the CWRU School of Medicine (1999-2017). Dr. Weiss is a past chair of the NIDDK Board of Scientific Counselors at the National Institutes of Health. He is a member of American Society for Clinical Investigation (ASCI) and American Association of Physicians (AAP).